• Services & Tools
    Services & Therapeutic areasTools
  • News & Events
    NewsEvents
  • Our expertise
    PublicationsPostersCasesTrainees' studies
  • About
    About InSysBioOur MissionOur LeadershipOur PartnersCareers
  • Blog
  • Contacts
    •
    insysbio@insysbio.com
    insysbio@insysbio.com
  • Services & Tools
    Services & Therapeutic areasTools
  • News & Events
    NewsEvents
  • Our expertise
    PublicationsPostersCasesTrainees' studies
  • About
    About InSysBioOur MissionOur LeadershipOur PartnersCareers
  • Blog
  • Contacts
    •
    Home Our expertise Posters ACoP 2024, Phoenix, AZ, US Development of QSP model of non-small cell lung cancer and its application to select optimal dose for acasunlimab, a bispecific antibody targeting 4-1BB and PD-L1